- Advertisement -

Related

Atlas Hit by Russian Exposure

- Advertisement -

Stockholm (HedgeNordic) – Themes-focused hedge fund Atlas Global Macro, co-managed by Danish CIO Lars Tvede and portfolio manager Jakob Due, had exposure to Russian securities as part of a commodity “supercycle” theme. As a result of shuttered markets and worldwide sanctions imposed after Russia’s invasion of Ukraine, Atlas Global Macro’s entire exposure to Russian securities has been deemed worthless by its independent administrator, hitting the fund’s performance by six percent. Atlas Global Macro is now down 11.6 percent this year through March 30.

Atlas Global Macro’s administrator, an entity under Credit Suisse called MultiConcept Fund Management S.A., held a meeting in their pricing committee and decided to re-evaluate the pricing of Russian exposure within all funds under their umbrella structure. “As Atlas is administered by MultiConcept, this also impacts the NAV of Atlas,” writes the team at Atlas Global Macro. “More specifically, it was decided to value the fund’s exposure to Russian equities to zero, which subtracts around 6pp.” The fund’s entire Russian exposure via exchange-traded funds (ETFs) is now worth zero.

“It was decided to value the fund’s exposure to Russian equities to zero, which subtracts around 6pp.”

Launched in May of last year, Atlas Global Macro is a global macro-focused fund based on themes. One of the themes reflected in the fund’s portfolio since inception has been a long-term commodity “supercycle,” which Danish entrepreneur and author Lars Tvede expects to last between five to ten years due to the massive underinvestment in the physical economy. “We have been invested in this commodity theme since the beginning of the fund, but unfortunately Russia has also been part of this theme and therefore the fund’s investment exposure given the country’s large production of oil, gas, metals and minerals,” wrote the Atlas Global Macro team back in March.

“The updated pricing can be seen as an absolute ‘worst-case scenario.’ The ETFs will be valued at zero until they start trading again.”

“The underlying equities are again actively traded on the Russian exchange indicating potentially significant positive impact for the NAV of Atlas,” writes the team at Atlas Global Macro. “However, given current trading and settlement restrictions applied by the EU, US and Russia, our Administrator finds it most prudent to apply the most conservative pricing methodology,” the team adds. “Hence, the updated pricing can be seen as an absolute ‘worst-case scenario.’ The ETFs will be valued at zero until they start trading again.”

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

Eugeniu Guzun
Eugeniu Guzun
Eugeniu Guzun serves as a data analyst responsible for maintaining and gatekeeping the Nordic Hedge Index, and as a journalist covering the Nordic hedge fund industry for HedgeNordic. Eugeniu completed his Master’s degree at the Stockholm School of Economics in 2018. Write to Eugeniu Guzun at eugene@hedgenordic.com

Latest Articles

Systematic Multi-Strategy as a Portfolio Diversifier

By Fredrik Langenskiöld – Union Bancaire Privée: Multi-strategy funds are those that allocate to more than one alternative strategy or portfolio manager (PM) in...

Visio Allocator Delivers Record Month on AI Chip Rally

After a more muted, albeit still challenging, first quarter, multi-strategy fund Visio Allocator regained momentum starting in April and delivered its strongest month on...

Colosseum’s Difficult Stretch Continues as Co-Portfolio Manager Departs

After a volatile journey since launching in mid-2025, Colosseum Global Alpha has suffered two consecutive months of steep losses, leaving the fund down more...

CABA Offers Another Roll Down the Curve

CABA Capital has launched the fourth iteration of its Flex strategy, a three-year closed-ended AAA-yield premium strategy designed to harvest roll-down and pull-to-par effects...

Even Steven for Nordic CTAs in Mediocre May

May was another month characterized by reversals and cross-asset volatility. Strong momentum in U.S. equities contrasted with directionless moves across other markets, creating a...

Rhenman Doubles Down on Smaller Healthcare Innovators with New Fund

Many of healthcare’s most transformative breakthroughs often originate not from established industry giants, but from smaller companies developing new technologies, therapies, and treatment approaches....

Allocator Interviews

In-Depth: Diversification

- Advertisement -

Voices

Request for Proposal

- Advertisement -